Provided by Tiger Trade Technology Pte. Ltd.

LIVZON PHARMA

26.140
-0.340-1.28%
Volume:74.30K
Turnover:1.96M
Market Cap:23.21B
PE:11.52
High:26.740
Open:26.480
Low:26.140
Close:26.480
52wk High:39.269
52wk Low:23.240
Shares:888.00M
HK Float Shares:300.00M
Volume Ratio:1.11
T/O Rate:0.02%
Dividend:1.64
Dividend Rate:6.28%
EPS(LYR):2.270
ROE:15.06%
ROA:6.59%
PB:1.38
PE(LYR):11.52
PS:1.71

Loading ...

Livzon Pharma Publishes 2025 Annual Report and AGM Materials Online; Shareholders Asked to Confirm E-Communication Preferences

Bulletin Express
·
Apr 23

LIVZON PHARMA (01513) to Distribute Final Dividend of RMB 14.3 per 10 Shares on July 13

Stock News
·
Apr 23

LIVZON PHARMA Reports Q1 Net Profit of 577 Million Yuan, Down 9.39%

Stock News
·
Apr 23

Livzon Pharma Q1 2026: Revenue and Profit Retreat While Cash Generation Improves

Bulletin Express
·
Apr 23

Livzon Pharma proposes Liu Daping as Executive Director and Kang Li as Independent Director

Bulletin Express
·
Apr 23

LIVZON PHARMA (01513) Nominates Liu Daping and Tang Yanggang as Executive Director Candidates

Stock News
·
Apr 23

LIVZON PHARMA Wins NMPA Clinical Trial Approval for JP-1366 Tablet Targeting Helicobacter pylori

Bulletin Express
·
Apr 10

LIVZON PHARMA (01513) Receives Approval for Clinical Trial of JP-1366 Tablets

Stock News
·
Apr 10

LIVZON PHARMA Schedules 23 April 2026 Board Meeting to Approve Q1 Results

Bulletin Express
·
Apr 08

Livzon Pharma Confirms Stable Share Capital and Adequate Public Float for March 2026

Bulletin Express
·
Apr 01

Livzon Pharma clarifies 2025 dividend: RMB14.30 per 10 shares, no bonus shares

Bulletin Express
·
Mar 26

LIVZON PHARMA (01513) Secures Clinical Trial Approval for Brexpiprazole Microsphere Injection

Stock News
·
Mar 26

Livzon Pharma Details New Board and Committee Line-up; Zhu Baoguo Continues as Chairman

Bulletin Express
·
Mar 24

LIVZON PHARMA 2025 ESG Report: 19.84% CO₂ Cut, 2055 Net-Zero Goal and RMB1.06 Billion R&D Outlay

Bulletin Express
·
Mar 24

Livzon Pharma to Distribute Final Dividend of RMB1.43 per Share for FY2025

Bulletin Express
·
Mar 24

Livzon Pharma Appoints Ran Yongmei to Strategy Committee, Tang Yanggang to Nomination Committee

Bulletin Express
·
Mar 24

LIVZON PHARMA Declares Final Dividend of RMB 14.3 per 10 Shares

Stock News
·
Mar 24

LIVZON PHARMA (01513) Announces New Board Committee Appointments

Stock News
·
Mar 24

LIVZON PHARMA to Invest Up to 2.5 Billion Yuan in Financial Products

Stock News
·
Mar 24

Vietnam Securities Regulator Approves Livzon Subsidiary's Acquisition of Imexpharm

MT Newswires Live
·
Mar 09